{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:56:31Z","timestamp":1792803391907,"version":"4.5.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41443-025-01055-0","type":"journal-article","created":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T09:41:02Z","timestamp":1743500462000},"page":"965-969","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparative outcomes of intralesional collagenase injection for Peyronie\u2019s disease: acute vs. stable phase treatment"],"prefix":"10.1038","volume":"37","author":[{"given":"Manish","family":"Kuchakulla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hriday P.","family":"Bhambhvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gal","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon P.","family":"Basourakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick J.","family":"Lewicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3213-2679","authenticated-orcid":false,"given":"James","family":"Kashanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"1055_CR1","first-page":"61","volume":"8","author":"KA Ostrowski","year":"2016","unstructured":"Ostrowski KA, Gannon JR, Walsh TJ. A review of the epidemiology and treatment of Peyronie\u2019s disease. Res Rep Urol. 2016;8:61\u201370.","journal-title":"Res Rep Urol"},{"key":"1055_CR2","doi-asserted-by":"publisher","first-page":"e0150157","DOI":"10.1371\/journal.pone.0150157","volume":"11","author":"M Stuntz","year":"2016","unstructured":"Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie\u2019s disease in the United States: A Population-Based Study. PLoS ONE. 2016;11:e0150157.","journal-title":"PLoS ONE"},{"key":"1055_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1743-6109.2004.10116.x","volume":"1","author":"J Pryor","year":"2004","unstructured":"Pryor J, Akkus E, Alter G, Jordan G, Lebret T, Levine L, et al. Peyronie\u2019s disease. J Sex Med. 2004;1:110\u20135.","journal-title":"J Sex Med"},{"key":"1055_CR4","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","volume":"171","author":"JP Mulhall","year":"2004","unstructured":"Mulhall JP, Creech SD, Boorjian SA, Ghaly S, Kim ED, Moty A, et al. Subjective and objective analysis of the prevalence of Peyronie\u2019s disease in a population of men presenting for prostate cancer screening. J Urol. 2004;171:2350\u20133.","journal-title":"J Urol"},{"key":"1055_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","volume":"194","author":"A Nehra","year":"2015","unstructured":"Nehra A, Alterowitz R, Culkin DJ, Faraday MM, Hakim LS, Heidelbaugh JJ, et al. Peyronie\u2019s disease: AUA guideline. J Urol. 2015;194:745\u201353.","journal-title":"J Urol"},{"key":"1055_CR6","unstructured":"U.S. Food and Drug Administration. Center for drug evaluation and research. XIAFLEX\u00ae (collagenase clostridium histolyticum) approval letter. 2013. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2013\/125338Orig1s0061ltr.pdf."},{"key":"1055_CR7","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","volume":"190","author":"M Gelbard","year":"2013","unstructured":"Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199\u2013207.","journal-title":"J Urol"},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.21037\/tau-22-188","volume":"11","author":"MY Hu","year":"2022","unstructured":"Hu MY, Sigalos JT, Walker DT, Li MK, Yoffe DA, Modiri N, et al. Intralesional collagenase clostridium histolyticum for acute phase Peyronie\u2019s disease: a single-center, retrospective cohort study. Transl Androl Urol. 2022;11:1074\u201382.","journal-title":"Transl Androl Urol"},{"key":"1055_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.urology.2020.07.048","volume":"145","author":"HMT Nguyen","year":"2020","unstructured":"Nguyen HMT, Yousif A, Chung A, Virasoro R, Tapscott A, Ziegelmann M, et al. Safety and efficacy of collagenase clostridium histolyticum in the treatment of acute phase Peyronie\u2019s disease: a multi-institutional analysis. Urology. 2020;145:147\u201351.","journal-title":"Urology"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1097\/JU.0000000000004072","volume":"212","author":"L Trost","year":"2024","unstructured":"Trost L, Mulhall J, Hellstrom W. Creation of a novel classification system (PTNM) for Peyronie\u2019s disease and penile curvature using evidence-based criteria. J Urol. 2024;212:470\u201382.","journal-title":"J Urol"},{"key":"1055_CR11","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.jsxm.2022.08.001","volume":"19","author":"JM Flores","year":"2022","unstructured":"Flores JM, Nascimento B, Punjani N, Salter CA, Bernie HL, Taniguchi H, et al. Predictors of curvature improvement in men with Peyronie\u2019s disease treated with intralesional collagenase clostridium histolyticum. J Sex Med. 2022;19:1680\u20136.","journal-title":"J Sex Med"},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5395\/rde.2017.42.2.152","volume":"42","author":"HY Kim","year":"2017","unstructured":"Kim HY. Statistical notes for clinical researchers: chi-squared test and Fisher\u2019s exact test. Restor Dent Endod. 2017;42:152\u20135.","journal-title":"Restor Dent Endod"},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00345-019-02791-x","volume":"38","author":"FM El-Khatib","year":"2020","unstructured":"El-Khatib FM, Towe M, Yafi FA. Management of Peyronie\u2019s disease with collagenase clostridium histolyticum in the acute phase. World J Urol. 2020;38:299\u2013304.","journal-title":"World J Urol"},{"key":"1055_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","volume":"190","author":"WJ Hellstrom","year":"2013","unstructured":"Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie\u2019s disease: validation of the Peyronie\u2019s disease questionnaire. J Urol. 2013;190:627\u201334.","journal-title":"J Urol"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01055-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01055-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:18:52Z","timestamp":1765527532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-025-01055-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1038\/s41443-025-01055-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5357895\/v1","asserted-by":"object"}]},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"29 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. This study was approved by Institutional Review Board (IRB # 20-07022335) of New York Presbyterian Hospital \u2013 Weill Cornell Medical Center. Due to the retrospective nature of the study, informed consent was not required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}